408 related articles for article (PubMed ID: 28935248)
41. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].
Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955
[TBL] [Abstract][Full Text] [Related]
42. [Distribution of peripheral blood lymphocyte subsets in 826 healthy children aged 0-6 years].
Zhan WL; Yang XH; Guo H; Zhong ZC; DU QY; Zhang CB; Huang BM; Liu H; Luo MY
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Feb; 21(2):180-183. PubMed ID: 30782284
[TBL] [Abstract][Full Text] [Related]
43. T lymphocyte subsets in primary antiphospholipid syndrome.
Papo T; Piette JC; Legac E; Frances C; Grenot P; Debre P; Godeau P; Autran B
J Rheumatol; 1994 Dec; 21(12):2242-5. PubMed ID: 7699624
[TBL] [Abstract][Full Text] [Related]
44. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
45. Thoracoscopic talc poudrage decreases T-lymphocytes in the peripheral blood.
Froudarakis ME; Papadaki HA; Klimathianaki M; Damianaki A; Pougounias M; Kotsianidis I; Astoul P
Respir Med; 2007 Jun; 101(6):1212-7. PubMed ID: 17182238
[TBL] [Abstract][Full Text] [Related]
46. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
47. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
48. [Change of cytokine expressions on bone marrow mesenchymal stem cells in patients with bone marrow failure syndromes and its significance].
Yang SM; Lu SF; Fei XM; Zhang JF; Shen WY; Li JY; Lu H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1560-3. PubMed ID: 21176370
[TBL] [Abstract][Full Text] [Related]
49. CD4+ T-Cell Subsets in Aplastic Anemia, Myelodysplastic Syndrome, and Acute Myelogenous Leukemia Patients: a Comparative Analysis.
Feng X; Xu H; Yin L; Yin D; Jiang Y
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436393
[TBL] [Abstract][Full Text] [Related]
50. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
[TBL] [Abstract][Full Text] [Related]
51. T-lymphocyte subsets and Th1/Th2 cytokines in convalescent patients with Epstein-Barr virus-associated aplastic anemia.
Chen T; Chen Y; Bao W; Lu W
Hematology; 2020 Dec; 25(1):11-16. PubMed ID: 31842718
[No Abstract] [Full Text] [Related]
52. Two-color flow cytometric analysis of preterm and term newborn lymphocytes.
Juretić E; Uzarević B; Petrovecki M; Juretić A
Immunobiology; 2000 Nov; 202(5):421-8. PubMed ID: 11205372
[TBL] [Abstract][Full Text] [Related]
53. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
Wu L; Li X; Chang C; Ying S; He Q; Pu Q
Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
[TBL] [Abstract][Full Text] [Related]
54. [Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes].
Tamai Y; Takami H; Nakahata R; Nakui Y; Suzuki Y; Akagi T; Kariya K; Tsushima K; Munakata A; Kawamura S
Rinsho Ketsueki; 1997 Dec; 38(12):1243-8. PubMed ID: 9455142
[TBL] [Abstract][Full Text] [Related]
55. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia.
Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z
Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
57. [Analysis of T cell subsets and CD3zeta chain expression in myelodysplastic syndrome patients].
Xu F; Liu T; Zhu HL; Cui X; Xu CG; Mao YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):779-82. PubMed ID: 15631660
[TBL] [Abstract][Full Text] [Related]
58. Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome.
Xu H; Li A; Yu Y; Li J; Liu X; Wang X; Wang X; Xu G
Int J Lab Hematol; 2009 Dec; 31(6):597-602. PubMed ID: 18637807
[TBL] [Abstract][Full Text] [Related]
59. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
Koh Y; Lee HR; Song EY; Kim HK; Kim I; Park S; Park MH; Kim BK; Yoon SS; Lee DS
Leuk Res; 2010 Oct; 34(10):1344-50. PubMed ID: 20427085
[TBL] [Abstract][Full Text] [Related]
60. Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia.
Qi W; Ren Y; Fu R; Wang H; Liu C; Shao Z
Turk J Haematol; 2015 Sep; 32(3):220-7. PubMed ID: 25912955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
